Earnings & Valuation
This table compares Glucose Health and its rivals gross revenue, earnings per share and valuation.
Gross Revenue | Net Income | Price/Earnings Ratio | |
Glucose Health | $540,000.00 | -$420,000.00 | -3.86 |
Glucose Health Competitors | $321.67 million | -$49.81 million | 16.42 |
Glucose Health’s rivals have higher revenue, but lower earnings than Glucose Health. Glucose Health is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.
Profitability
This table compares Glucose Health and its rivals’ net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
Glucose Health | -75.00% | N/A | N/A |
Glucose Health Competitors | -41.00% | -261.24% | -7.37% |
Insider and Institutional Ownership
Volatility & Risk
Glucose Health has a beta of 3.51, meaning that its stock price is 251% more volatile than the S&P 500. Comparatively, Glucose Health’s rivals have a beta of 1.29, meaning that their average stock price is 29% more volatile than the S&P 500.
Summary
Glucose Health rivals beat Glucose Health on 5 of the 9 factors compared.
About Glucose Health
Glucose Health, Inc. engages in the formulation, manufacturing, marketing, and distribution of soluble fiber infused nutritional beverages. It offers soluble fiber infused powdered iced tea, and flavored drink mixes for pre-diabetic and diabetic persons under the GLUCODOWN brand in North America. The company was formerly known as Bio-Solutions Corp. and changed its name to Glucose Health, Inc. in November 2014. Glucose Health, Inc. was incorporated in 2007 and is based in Bentonville, Arkansas.
Receive News & Ratings for Glucose Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Glucose Health and related companies with MarketBeat.com's FREE daily email newsletter.